Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Jul 1;25(4):345-353.
doi: 10.4062/biomolther.2016.126.

Production of Recombinant Anti-Cancer Vaccines in Plants

Affiliations
Review

Production of Recombinant Anti-Cancer Vaccines in Plants

Jeong Hwan Lee et al. Biomol Ther (Seoul). .

Abstract

Plant expression systems have been developed to produce anti-cancer vaccines. Plants have several advantages as bioreactors for the production of subunit vaccines: they are considered safe, and may be used to produce recombinant proteins at low production cost. However, several technical issues hinder large-scale production of anti-cancer vaccines in plants. The present review covers design strategies to enhance the immunogenicity and therapeutic potency of anti-cancer vaccines, methods to increase vaccine-expressing plant biomass, and challenges facing the production of anti-cancer vaccines in plants. Specifically, the issues such as low expression levels and plant-specific glycosylation are described, along with their potential solutions.

Keywords: Cancer; Glycosylation; Plant expression system; Recombinant protein; Subunit vaccine; Vaccine.

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST

The authors confirm that they have no conflicts of interest.

Figures

Fig. 1.
Fig. 1.
Plant N-glycosylation pathway and its profile of cancer vaccine expressed in plants. (A) Glycosylation processing pathway in plant (modified from Jamal et al., 2009). (B) The comparative amount of plant-derived colorectal cancer antigen GA733-FcK protein expression level and the ratio of Golgi/endoplasmic reticulum-type glycans along with growth periods (modified from Lim et al., 2015).

Similar articles

Cited by

References

    1. Andrianov V, Brodzik R, Spitsin S, Bandurska K, McManus H, Koprowski H, Golovkin M. Production of recombinant anthrax toxin receptor (ATR/CMG2) fused with human Fc in planta. Protein Expr Purif. 2010;70:158–162. doi: 10.1016/j.pep.2009.09.016. - DOI - PubMed
    1. Bachmann MF, Jennings GT. Vaccine delivery: a matter of size, geometry, kinetics and molecular patterns. Nat Rev Immunol. 2010;10:787–796. doi: 10.1038/nri2868. - DOI - PubMed
    1. Bendandi M, Marillonnet S, Kandzia R, Thieme F, Nickstadt A, Herz S, Fröde R, Inogés S, López-Dìaz de Cerio A, Soria E, Villanueva H, Vancanneyt G, McCormick A, Tusé D, Lenz J, Butler-Ransohoff JE, Klimyuk V, Gleba Y. Rapid, high-yield production in plants of individualized idiotype vaccines for non-Hodgkin’s lymphoma. Ann Oncol. 2010;21:2420–2427. doi: 10.1093/annonc/mdq256. - DOI - PubMed
    1. Bhoo SH, Lai H, Ma J, Arntzen CJ, Chen Q, Mason HS. Expression of an immunogenic Ebola immune complex in Nicotiana benthamiana. Plant Biotechnol J. 2006;9:807–816. - PMC - PubMed
    1. Brodzik R, Glogowska M, Bandurska K, Okulicz M, Deka D, Ko K, van der Linden J, Leusen JH, Pogrebnyak N, Golovkin M, Steplewski Z, Koprowski H. Plant-derived anti-Lewis Y mAb exhibits biological activities for efficient immunotherapy against human cancer cells. Proc Nati Acad Sci USA. 2006;103:8804–8809. doi: 10.1073/pnas.0603043103. - DOI - PMC - PubMed

LinkOut - more resources